#SalivaryGlandCancer
I’m 4 month post op from having 2 parotidectomies back to back to remove cancer, a bunch of lymph nodes, and a chunk of flesh. this is my scarring. Still no movement in the lower left of my mouth, and my ear is still 1/2 dead too

#parotidectomy #aciniccellcarcinoma #salivaryglandcancer #bellspalsy
February 4, 2025 at 2:37 AM
I'm done for today
10,300+ steps
Falling asleep...

#walking #challenge #support #salivaryglandcancer #charity
June 9, 2026 at 8:38 PM
Another inspiring #ASCO25 poster session is starting soon! Alan Ho, MD, PhD, will share results of a phase 2 study of lenvatinib plus pembrolizumab in individuals with recurrent/metastatic #salivaryglandcancer. @mskcancercenter.bsky.social @ascocancer.bsky.social
Learn more: bit.ly/4kL6TSr
June 2, 2025 at 1:27 PM
Fingers crossed I don’t have many surgeries left in me, but somebody in my support group was asking how our scars are looking. This is me 9 years later. The little white dots are drains from various and numerous procedures. #salivaryglandcancer survivor.
December 3, 2025 at 12:38 AM
30-minute countdown to MSK expert Dr. Alan Ho's session on #salivaryglandcancer research. #ASCO25. ⬇️
Another inspiring #ASCO25 poster session is starting soon! Alan Ho, MD, PhD, will share results of a phase 2 study of lenvatinib plus pembrolizumab in individuals with recurrent/metastatic #salivaryglandcancer. @mskcancercenter.bsky.social @ascocancer.bsky.social
Learn more: bit.ly/4kL6TSr
June 2, 2025 at 1:29 PM
This just in JHC: "P63 and Tight Junctions Targeted for Therapy in Human Salivary Duct Adenocarcinoma Cells."

Click to read: journals.sagepub.com/doi/abs/10.1...

#salivaryglandcancer #histopathology
September 8, 2026 at 8:41 PM
This just in JHC: "P63 and Tight Junctions Targeted for Therapy in Human Salivary Duct Adenocarcinoma Cells."

Click to read: journals.sagepub.com/doi/abs/10.1...

#salivaryglandcancer #histopathology
August 20, 2026 at 10:46 PM
🧬🎯 Trastuzumab rezetecan demonstrated high objective response rates in patients with HER2-high and HER2-low salivary gland carcinoma.
Read more ➡️ www.onclive.com/view/trastuz...
#SalivaryGlandCancer #HER2 #ADC #AntibodyDrugConjugate #TargetedTherapy #PrecisionOncology #HeadAndNeckCancer #Oncology
Trastuzumab Rezetecan Elicits High ORR in HER2-High and HER2-Low Salivary Gland Carcinoma | OncLive
The HER2-directed ADC produced confirmed responses across both biomarker-defined cohorts of advanced salivary gland carcinoma.
www.onclive.com
August 14, 2026 at 1:27 PM
This just in JHC: "P63 and Tight Junctions Targeted for Therapy in Human Salivary Duct Adenocarcinoma Cells."

Click to read: journals.sagepub.com/doi/abs/10.1...

#salivaryglandcancer #histopathology
August 11, 2026 at 4:12 PM
This just in JHC: "P63 and Tight Junctions Targeted for Therapy in Human Salivary Duct Adenocarcinoma Cells."

Click to read: journals.sagepub.com/doi/abs/10.1...

#salivaryglandcancer #histopathology
August 3, 2026 at 9:51 PM
This just in JHC: "P63 and Tight Junctions Targeted for Therapy in Human Salivary Duct Adenocarcinoma Cells."

Click to read: journals.sagepub.com/doi/abs/10.1...

#salivaryglandcancer #histopathology
July 20, 2026 at 6:47 PM